169 related articles for article (PubMed ID: 22326811)
1. Comparative study of nanoparticle-mediated transfection in different GI epithelium co-culture models.
Loo Y; Grigsby CL; Yamanaka YJ; Chellappan MK; Jiang X; Mao HQ; Leong KW
J Control Release; 2012 May; 160(1):48-56. PubMed ID: 22326811
[TBL] [Abstract][Full Text] [Related]
2. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
3. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
[TBL] [Abstract][Full Text] [Related]
4. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
[TBL] [Abstract][Full Text] [Related]
5. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
6. Models and methods to evaluate transport of drug delivery systems across cellular barriers.
Ghaffarian R; Muro S
J Vis Exp; 2013 Oct; (80):e50638. PubMed ID: 24192611
[TBL] [Abstract][Full Text] [Related]
7. Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes.
Kadiyala I; Loo Y; Roy K; Rice J; Leong KW
Eur J Pharm Sci; 2010 Jan; 39(1-3):103-9. PubMed ID: 19913612
[TBL] [Abstract][Full Text] [Related]
8. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
9. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C
J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042
[TBL] [Abstract][Full Text] [Related]
11. The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.
Thwala LN; Beloqui A; Csaba NS; González-Touceda D; Tovar S; Dieguez C; Alonso MJ; Préat V
J Control Release; 2016 Dec; 243():109-120. PubMed ID: 27720993
[TBL] [Abstract][Full Text] [Related]
12. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
Ke Z; Guo H; Zhu X; Jin Y; Huang Y
J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
[TBL] [Abstract][Full Text] [Related]
13. A comparison of three Peyer's patch "M-like" cell culture models: particle uptake, bacterial interaction, and epithelial histology.
Ahmad T; Gogarty M; Walsh EG; Brayden DJ
Eur J Pharm Biopharm; 2017 Oct; 119():426-436. PubMed ID: 28754262
[TBL] [Abstract][Full Text] [Related]
14. Prolonging the expression duration of ultrasound-mediated gene transfection using PEI nanoparticles.
Lee JL; Lo CW; Ka SM; Chen A; Chen WS
J Control Release; 2012 May; 160(1):64-71. PubMed ID: 22465392
[TBL] [Abstract][Full Text] [Related]
15. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
Lopes M; Shrestha N; Correia A; Shahbazi MA; Sarmento B; Hirvonen J; Veiga F; Seiça R; Ribeiro A; Santos HA
J Control Release; 2016 Jun; 232():29-41. PubMed ID: 27074369
[TBL] [Abstract][Full Text] [Related]
16. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
17. Morphofunctional properties of a differentiated Caco2/HT-29 co-culture as an
Ferraretto A; Bottani M; De Luca P; Cornaghi L; Arnaboldi F; Maggioni M; Fiorilli A; Donetti E
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29540534
[TBL] [Abstract][Full Text] [Related]
18. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.
Antunes F; Andrade F; Araújo F; Ferreira D; Sarmento B
Eur J Pharm Biopharm; 2013 Apr; 83(3):427-35. PubMed ID: 23159710
[TBL] [Abstract][Full Text] [Related]
20. An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers.
Primavera R; Palumbo P; Celia C; Cinque B; Carata E; Carafa M; Paolino D; Cifone MG; Di Marzio L; Cilurzo F
Eur J Pharm Biopharm; 2018 Jun; 127():432-442. PubMed ID: 29605467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
